Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 15Colonic Neoplasms 3Colorectal Neoplasms, Hereditary Nonpolyposis 2Anus Neoplasms 2Adenomatous Polyposis Coli 2Turcot syndrome 1Rectal Neoplasms 1Polyps 1Pathologic Complete Response 1Lymphoma, Mantle-Cell 1HIV Infections 1Disease 1Digestive System Diseases 1Colon Cancer Screening 1Colitis, Ulcerative 1Benign Colorectal Neoplasm 1Anal Canal Carcinoma 1Adenoma 1

Interventions

Oxaliplatin 27Fluorouracil 23Cetuximab 23Leucovorin 22Bevacizumab 21Nivolumab 16Capecitabine 16Irinotecan 15pembrolizumab 12Magnetic Resonance Spectroscopy 11Specimen Handling 10encorafenib 8Folfox protocol 7trifluridine tipiracil drug combination 6Ipilimumab 6Exercise 6regorafenib 5fludarabine 5cemiplimab 5Trastuzumab 5Gemcitabine 5Cyclophosphamide 5Cisplatin 5Blood Specimen Collection 5Biopsy 5pertuzumab 4adagrasib 4Trifluridine 4Surgical Procedures, Operative 4Pemetrexed 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Colonic Neoplasms × Colonoscopy × 1 year × Clear all
NCT07502469 2026-03-31

BENEFIT

Elsan

Completed
341 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT07503847 2026-03-31

Shared Decision-Making for Colorectal Cancer Screening in High-Risk First-Degree Relatives Aged 40-49

National Taiwan University Hospital

Phase NA Enrolling by invitation
2,286 enrolled
Gastrointestinal

Colonic Neoplasms

NCT07140679 2025-09-25

Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer

Emory University

Phase 2 Recruiting
40 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡